The age old question remains if in fact top tier venture firms actually add more value to companies after the investment or if they pick the best investments which just have a high chance of getting a greater return. Is it a product of deal-flow, selecting the right...

Conventional wisdom states that a company who accepts money from a top tier VC firm will receive more value add from these venture capitalists and thus the company should accept a lower valuation for that investment than if another less reputable venture firm offers...

As part of my experience at SR One, I waded through 30+ term sheets for portfolio companies as well as deals in diligence and ones that were passed on. After looking at enough term sheets, you start to get the idea about what is market, what is desired, and why you...

As founder of a biotech networking event in the Philadelphia area, Philly BioBreak, I’m often asked about how to effectively and efficiently network to both advance your career as well as find a new one. I’ll continue talking about this in future posts but...

Why is dilution a bad word? It is the lifeblood of biotech so this seems backward. Dilution is only bad when someone else pays less per share than you did. You have to mark your position to market writing off or up the difference in value (number of shares purchased...